Prof. Dr. Hatem A. Abuelizz is a distinguished researcher in medicinal chemistry and pharmaceutical biotechnology, with significant contributions to drug discovery and molecular design. His work emphasizes the synthesis and biological evaluation of quinazoline-based compounds with anticancer, antiviral, and antimicrobial potential. He has authored 147 Scopus-indexed publications, achieving 1,746 citations across 1,395 documents and an h-index of 24, reflecting strong research impact. His portfolio includes patented innovations and interdisciplinary studies integrating molecular docking and bioactivity evaluation, demonstrating excellence and sustained contribution to pharmaceutical research and innovation.